- Home
- FRSH vs RNA Comparison
FRSH vs RNA Comparison
Compare FRSH & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSH
- RNA
- Stock Information
- Founded
- FRSH 2010
- RNA 2012
- Country
- FRSH United States
- RNA United States
- Employees
- FRSH N/A
- RNA 391
- Industry
- FRSH EDP Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- FRSH Technology
- RNA Health Care
- Exchange
- FRSH Nasdaq
- RNA Nasdaq
- Market Cap
- FRSH 4.4B
- RNA 3.6B
- IPO Year
- FRSH 2021
- RNA 2020
- Fundamental
- Price
- FRSH $14.74
- RNA $29.31
- Analyst Decision
- FRSH Buy
- RNA Strong Buy
- Analyst Count
- FRSH 15
- RNA 14
- Target Price
- FRSH $20.00
- RNA $68.00
- AVG Volume (30 Days)
- FRSH 2.4M
- RNA 1.5M
- Earning Date
- FRSH 07-29-2025
- RNA 08-08-2025
- Dividend Yield
- FRSH N/A
- RNA N/A
- EPS Growth
- FRSH N/A
- RNA N/A
- EPS
- FRSH N/A
- RNA N/A
- Revenue
- FRSH $751,550,000.00
- RNA $8,927,000.00
- Revenue This Year
- FRSH $15.98
- RNA N/A
- Revenue Next Year
- FRSH $12.39
- RNA $155.06
- P/E Ratio
- FRSH N/A
- RNA N/A
- Revenue Growth
- FRSH 20.46
- RNA N/A
- 52 Week Low
- FRSH $10.81
- RNA $21.51
- 52 Week High
- FRSH $19.77
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- FRSH 44.53
- RNA 42.04
- Support Level
- FRSH $14.87
- RNA $31.59
- Resistance Level
- FRSH $15.54
- RNA $38.00
- Average True Range (ATR)
- FRSH 0.43
- RNA 2.01
- MACD
- FRSH -0.12
- RNA -0.59
- Stochastic Oscillator
- FRSH 5.76
- RNA 9.67
About FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.